David Y.T. Chen

8.9k total citations · 1 hit paper
134 papers, 5.3k citations indexed

About

David Y.T. Chen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, David Y.T. Chen has authored 134 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Pulmonary and Respiratory Medicine, 49 papers in Surgery and 45 papers in Molecular Biology. Recurrent topics in David Y.T. Chen's work include Renal cell carcinoma treatment (58 papers), Bladder and Urothelial Cancer Treatments (42 papers) and Renal and related cancers (39 papers). David Y.T. Chen is often cited by papers focused on Renal cell carcinoma treatment (58 papers), Bladder and Urothelial Cancer Treatments (42 papers) and Renal and related cancers (39 papers). David Y.T. Chen collaborates with scholars based in United States, Taiwan and Vietnam. David Y.T. Chen's co-authors include Robert G. Uzzo, Richard E. Greenberg, Rosalia Viterbo, Alexander Kutikov, Marc C. Smaldone, Paul L. Crispen, Daniel Canter, Arnim Pause, Richard D. Klausner and Wilson H. Burgess and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

David Y.T. Chen

127 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Natural History of Observed Enhancing Renal Masses: Meta-Analysis and Review of the World Literature

2006 518 citations Paul L. Crispen, Richard E. Greenberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Y.T. Chen United States	38	3.6k	3.1k	1.4k	1.0k	808	134	5.3k
Didier Jacqmin France	37	3.0k 0.8×	2.1k 0.7×	1.4k 1.0×	740 0.7×	609 0.8×	130	4.7k
Paul L. Crispen United States	36	2.7k 0.8×	2.1k 0.7×	1.3k 0.9×	589 0.6×	907 1.1×	107	4.1k
José A. Karam United States	43	4.7k 1.3×	3.4k 1.1×	2.5k 1.7×	1.8k 1.7×	1.5k 1.9×	274	7.0k
Hanjong Ahn South Korea	35	3.2k 0.9×	1.3k 0.4×	1.8k 1.2×	632 0.6×	574 0.7×	306	4.8k
Gladell P. Paner United States	41	3.2k 0.9×	1.8k 0.6×	2.4k 1.6×	924 0.9×	1.1k 1.4×	149	5.8k
Andres Jan Schrader Germany	34	2.0k 0.6×	1.1k 0.4×	707 0.5×	844 0.8×	1.2k 1.5×	162	3.8k
Jacques Tostain France	34	3.3k 0.9×	2.5k 0.8×	1.2k 0.8×	1.1k 1.1×	667 0.8×	72	4.1k
D. Scott Ernst Canada	30	2.8k 0.8×	1.2k 0.4×	925 0.6×	767 0.7×	1.8k 2.2×	77	4.3k
Hiro‐omi Kanayama Japan	35	1.4k 0.4×	1.9k 0.6×	967 0.7×	967 0.9×	1.0k 1.3×	195	4.0k
Frédéric Pouliot Canada	31	2.8k 0.8×	1.8k 0.6×	647 0.4×	1.1k 1.0×	1.4k 1.8×	196	4.5k

Countries citing papers authored by David Y.T. Chen

Since Specialization

Citations

This map shows the geographic impact of David Y.T. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Y.T. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Y.T. Chen more than expected).

Fields of papers citing papers by David Y.T. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Y.T. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Y.T. Chen. The network helps show where David Y.T. Chen may publish in the future.

Co-authorship network of co-authors of David Y.T. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of David Y.T. Chen. A scholar is included among the top collaborators of David Y.T. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Y.T. Chen. David Y.T. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roth, H, et al.. (2026). Artificial intelligence for early detection of pancreatic cancer in prediagnostic and diagnostic computed tomography examinations: A multicenter retrospective case-control study. Diagnostic and Interventional Imaging.

Chen, David Y.T., et al.. (2025). Brain modulatory effects of rehabilitation interventions in fibromyalgia: a systematic review of magnetic resonance imaging studies. Neurological Sciences. 46(5). 2041–2054.

Ruth, Karen, M.A. Hallman, David Y.T. Chen, et al.. (2024). Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer. Brachytherapy. 23(5). 559–568. 2 indexed citations

Deng, Mengying, Elizabeth Handorf, Jonathan J. Paly, et al.. (2021). Early Prostate-Specific Antigen Kinetics for Low- and Intermediate-Risk Prostate Cancer Treated With Definitive Radiation Therapy. Practical Radiation Oncology. 12(1). 60–67.

Figlin, Robert A., Nizar M. Tannir, Robert G. Uzzo, et al.. (2020). Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 26(10). 2327–2336. 53 indexed citations

Chen, Chi-Jen, et al.. (2020). Black Dipole or White Dipole: Using Susceptibility Phase Imaging to Differentiate Cerebral Microbleeds from Intracranial Calcifications. American Journal of Neuroradiology. 41(8). 1405–1413. 4 indexed citations

Tagai, Erin K., Suzanne M. Miller, Alexander Kutikov, et al.. (2018). Prostate Cancer Patients’ Understanding of the Gleason Scoring System: Implications for Shared Decision-Making. Journal of Cancer Education. 34(3). 441–445. 16 indexed citations

Joshi, Shreyas, Karen Ruth, Marc C. Smaldone, et al.. (2018). Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy. PubMed. 2(1). 47–55. 2 indexed citations

Zaorsky, Nicholas G., Jeff M. Martin, Karen Ruth, et al.. (2016). Patient reported outcomes among treatment modalities for prostate cancer.. PubMed. 23(6). 8535–8545. 16 indexed citations

10.

Ginzburg, Serge, Robert G. Uzzo, J.T. Walton, et al.. (2015). Residual Parenchymal Volume, Not Warm Ischemia Time, Predicts Ultimate Renal Functional Outcomes in Patients Undergoing Partial Nephrectomy. Urology. 86(2). 300–306. 55 indexed citations

11.

Martin, Jeff M., Tianyu Li, Colin T. Murphy, et al.. (2015). Use of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center. Journal of the National Comprehensive Cancer Network. 13(5). 525–530. 1 indexed citations

12.

Tomaszewski, Jeffrey, Robert G. Uzzo, Alexander Kutikov, et al.. (2014). Assessing the Burden of Complications After Surgery for Clinically Localized Kidney Cancer by Age and Comorbidity Status. Urology. 83(4). 843–850. 55 indexed citations

13.

Ross, Eric A., Robert G. Uzzo, David Y.T. Chen, et al.. (2012). Assessing the Clinical Role of Genetic Markers of Early-Onset Prostate Cancer among High-Risk Men Enrolled in Prostate Cancer Early Detection. Cancer Epidemiology Biomarkers & Prevention. 21(1). 53–60. 11 indexed citations

14.

Stoyanova, Radka, Niraj Pahlajani, Brian L. Egleston, et al.. (2012). The impact of dose‐escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms. Cancer. 119(5). 1080–1088. 13 indexed citations

15.

Scoll, Benjamin, Robert G. Uzzo, David Y.T. Chen, et al.. (2010). Robot-assisted Partial Nephrectomy: A Large Single-institutional Experience. Urology. 75(6). 1328–1334. 105 indexed citations

16.

Giri, Veda N., Karen Ruth, Robert G. Uzzo, et al.. (2010). Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high‐risk men: effect of TMPRSS2 Met160Val. British Journal of Urology. 107(3). 466–470. 15 indexed citations

17.

Crispen, Paul L., Rosalia Viterbo, Stephen A. Boorjian, et al.. (2009). Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer. 115(13). 2844–2852. 148 indexed citations

18.

Kaplan, David, Paul L. Crispen, Richard E. Greenberg, et al.. (2008). Residual Prostate Cancer After Radiotherapy: A Study of Radical Cystoprostatectomy Specimens. Urology. 72(3). 654–658. 8 indexed citations

19.

Eade, Thomas, Eric M. Horwitz, Karen Ruth, et al.. (2008). A Comparison of Acute and Chronic Toxicity for Men With Low-Risk Prostate Cancer Treated With Intensity-Modulated Radiation Therapy or 125I Permanent Implant. International Journal of Radiation Oncology*Biology*Physics. 71(2). 338–345. 54 indexed citations

20.

Eade, Thomas, Tahseen Al‐Saleem, Eric M. Horwitz, et al.. (2007). Role of radiotherapy in ductal (endometrioid) carcinoma of the prostate. Cancer. 109(10). 2011–2015. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact